Molecular Medicine Tri-Conference 2010

Small GW, Moody TD, Siddarth P, et al. Your brain on Google: patterns of cerebral activation during internet searching. Am J Geriatr Psychiatry 2009 Feb; 17(2): 116–26 Goldhirsch A, Ingle JN, Gelber RD, et al. Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009. Ann Oncol 2009; 20(8): 1319–29 Haybittle JL, Blamey RW, Elston CW, et al. A prognostic index in primary breast cancer. Br J Cancer 1982; 5(3): 361–6 US FDA. Mammaprint 510k summary [online]. Available from URL: http://www.accessdata.fda.gov/cdrh_docs/pdf8/K081092.pdf [Accessed 2010 Mar 17] European Organization for Research and Treatment of Cancer. Genetic testing or clinical assessment in determining the need for chemotherapy in women with breast cancer that involves no more than 3 lymph nodes (MINDACT) [Clinical-Trials.gov identifier NCT00433589]. US National Institutes of Health, Clinical-Trials.gov [online]. Available from URL: http://clinicaltrials.gov/ct2/show/NCT00433589?term=mindact&rank=1 [Accessed 2010 Mar 17]